CMS Proposes 2027 Oncology Reimbursement Cuts

The Centers for Medicare & Medicaid Services (CMS) has proposed a 2027 Medicare physician fee schedule that includes a 1.5% payment reduction for hematology/oncology services. This estimate was provided by the American Society of Clinical Oncology (ASCO), which also noted a projected 1.5% increase for radiation oncology services under the same proposal. The proposed cuts are part of a broader adjustment to Medicare reimbursement rates for physicians, aiming to recalibrate payments across various specialties.

ASCO has expressed significant concern over the proposed cuts, arguing that they could negatively impact patient access to essential cancer care. The organization stated that such reductions may force oncology practices to scale back services, delay necessary treatments, or even close their doors, particularly in underserved areas. The society plans to submit formal comments to CMS detailing the potential adverse effects on cancer patients and the oncology workforce. The final rule for the 2027 physician fee schedule is expected later this year, after which the full impact of these proposed changes will become clearer.

In addition to the reimbursement discussions, the article touches upon unrelated topics including research into cancer-prone geckos and actor Sam Neill's personal experience with a rare blood cancer. These elements are presented as distinct news items and do not directly relate to the CMS reimbursement proposals affecting oncology practices.